Millennium Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-66,180
| Closed | -$105K | – | 4830 |
|
|
2024
Q1 | $105K | Sell |
66,180
-1,196,215
| -95% | -$1.9M | ﹤0.01% | 3814 |
|
|
2023
Q4 | $1.08M | Buy |
1,262,395
+1,051,272
| +498% | +$903K | ﹤0.01% | 2791 |
|
|
2023
Q3 | $226K | Buy |
211,123
+95,519
| +83% | +$102K | ﹤0.01% | 3560 |
|
|
2023
Q2 | $299K | Sell |
115,604
-547,362
| -83% | -$1.42M | ﹤0.01% | 3525 |
|
|
2023
Q1 | $2.71M | Buy |
662,966
+204,736
| +45% | +$835K | ﹤0.01% | 2334 |
|
|
2022
Q4 | $2.3M | Buy |
458,230
+227,384
| +99% | +$1.14M | ﹤0.01% | 2624 |
|
|
2022
Q3 | $3.02M | Sell |
230,846
-210,629
| -48% | -$2.75M | ﹤0.01% | 2584 |
|
|
2022
Q2 | $5.66M | Buy |
441,475
+24,059
| +6% | +$308K | ﹤0.01% | 2052 |
|
|
2022
Q1 | $6.37M | Sell |
417,416
-116,933
| -22% | -$1.78M | ﹤0.01% | 2058 |
|
|
2021
Q4 | $9.46M | Buy |
534,349
+358,407
| +204% | +$6.35M | ﹤0.01% | 1637 |
|
|
2021
Q3 | $3.7M | Buy |
175,942
+154,441
| +718% | +$3.25M | ﹤0.01% | 2481 |
|
|
2021
Q2 | $424K | Buy |
+21,501
| New | +$424K | ﹤0.01% | 4296 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4996 |
|
|
2020
Q4 | – | Sell |
-89,803
| Closed | -$1.43K | – | 4477 |
|
|
2020
Q3 | $1.43K | Buy |
89,803
+78,100
| +667% | +$1.24K | ﹤0.01% | 2249 |
|
|
2020
Q2 | $231K | Sell |
11,703
-83,379
| -88% | -$1.65M | ﹤0.01% | 3065 |
|
|
2020
Q1 | $1.17M | Buy |
95,082
+26,647
| +39% | +$328K | ﹤0.01% | 1907 |
|
|
2019
Q4 | $1.27M | Buy |
68,435
+54,108
| +378% | +$1M | ﹤0.01% | 2346 |
|
|
2019
Q3 | $198K | Sell |
14,327
-34,689
| -71% | -$479K | ﹤0.01% | 3148 |
|
|
2019
Q2 | $718K | Buy |
+49,016
| New | +$718K | ﹤0.01% | 2551 |
|